Quick Answer
Intellia Therapeutics, Inc. reported Total Revenue of $67.67 million for fiscal year 2025.
Intellia Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $67.67M | +16.9% |
| 2024 | $57.88M | +59.6% |
| 2023 | $36.27M | -30.4% |
| 2022 | $52.12M | +57.7% |
| 2021 | $33.05M | -43.0% |
| 2020 | $57.99M | +34.5% |
| 2019 | $43.10M | +41.6% |
| 2018 | $30.43M | +16.5% |
| 2017 | $26.12M | +58.5% |
| 2016 | $16.48M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.78M | +51.3% | -3.3% |
| June 30, 2025 | $14.24M | +104.8% | -14.3% |
| March 31, 2025 | $16.63M | -42.5% | +82.5% |
| September 30, 2024 | $9.11M | -24.0% | +31.0% |
| June 30, 2024 | $6.96M | -48.8% | -76.0% |
| March 31, 2024 | $28.93M | +129.5% | +141.3% |
| September 30, 2023 | $11.99M | -9.6% | -11.8% |
| June 30, 2023 | $13.59M | -3.1% | +7.8% |
- Intellia Therapeutics, Inc. showed an increase of +16.9% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Intellia Therapeutics, Inc.’s total revenue has grown by 310.6% (from $16.48 million to $67.67 million).
- The most recent figure is from Intellia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: